Piramal Healthcare in talks to buy out Enam Financial’s stake in ING Life Insurance

20 Jul 2011 Evaluate

Piramal Healthcare, which sold its generics unit to Abbott Laboratories for $3.8 billion (Rs 17,190 crore) last year, is taking its second step to transform into a financial services conglomerate as it negotiates to buy Enam Financial's stake in ING Life Insurance. The insurance company, in which battery maker Exide Industries and retired investment banker Hemendra Kothari hold stakes, may be valued at Rs 2,400 crore

ING Life Insurance was established in 2001 as a joint venture between ING International, ING Vysya Bank and GMR Industries. In 2005, GMR industries sold its entire stake to Exide. . n 2010, Ambuja Cements sold its 11.5% stake in ING Life Insurance for Rs 190 crore to Hemendra Kothari, who once partnered Merrill Lynch in India. During 2010-11, stakeholders invested Rs 240 crore to improve its capital. Its solvency margin was Rs 360 crore at the end of March 2011. Now, Exide holds nearly 50% in the insurance company while Dutch financial major ING holds 26%. Enam Financial holds 12.5% and Kothari the rest. ING Life India had a net profit of Rs 7 crore in the fourth quarter of 2010-11. The company aims to break even by 2013. 

Piramal has sought the Reserve Bank of India's permission to incorporate a financial services company that may lend to infrastructure projects, among other activities in the financial services sector. In May, the drugmaker agreed to acquire Indiareit Fund Advisors, which manages 3,800 crore worth of real estate assets, for Rs 225 crore. crackcrack

Piramal Enterprises Share Price

795.55 -4.35 (-0.54%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Bajaj Finance 6702.50
Shriram Finance 2352.85
Aditya Birla Capital 223.85
SBI Cards AndPayment 692.15
Chola Invest & Fin. 1238.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.